.svg){kind=small}
Sep-2026
Sales
Trend
6-Month
Product Count
SKUs
Avg Price
YoY Sales Change
YoY Price Change
Where to Buy
Lobo is stocked at 60 licensed dispensaries across New York and New Jersey, 46 of them in New York, with the deepest coverage in New York, Queens, Brooklyn, Staten Island, and Rochester. Search by ZIP code or city below to find the closest one, or filter by product type if you are after a specific format.
Market Insights Snapshot
Lobo’s category mix in September 2026 tilted toward Flower at 49.2% share, yet that anchor shrank with a 41.25% year-over-year decline and a 12.56% month-over-month drop, while Pre-Roll at 31.37% share retreated faster at 58.10% YoY and 26.73% MoM. In contrast, Concentrates rose 56.99% YoY to 19.42% share but eased 3.96% MoM, indicating a partial offset that did not counterbalance the overall brand sales decline of 41.52% YoY and the average price decrease of 17.14% YoY. With Flower performance placing Lobo at rank 88 in New York, the mix suggests reliance on a contracting base while the only expanding category YoY remains subscale, implying that September 2026 was a rebalancing month where growth in Concentrates was insufficient to stabilize aggregate momentum.
The shifts imply a positioning drift away from price-led volume in core Flower and Pre-Roll toward a higher-engagement niche in Concentrates, but the 3.96% MoM dip in Concentrates and the 12.56% MoM contraction in Flower point to limited near-term carry-through. Given a 31.37% share in Pre-Roll alongside a 26.73% MoM decline and a 17.14% YoY drop in average price, discounting did not convert to share gains, and a rank of 88 in New York for Flower underscores insufficient differentiation in the largest bucket; net effect, Lobo’s September 2026 profile implies the need to concentrate assortment and price architecture where the 56.99% YoY growth signal exists while controlling exposure to categories showing simultaneous share weight and double-digit MoM contraction.
Competitive Landscape
Lobo sits at #88 in NY Flower in September 2026, down 26 ranks year over year from #62, and 8 ranks below its June 2026 position of #80; this follows a prior peak at #48 in November 2025, marking a 40-rank slide from that high. In contrast, Find. climbed from #5 to #1 with a 16.2% year-over-year sales increase, while Grassroots advanced from #15 to #2 alongside a 150.3% year-over-year sales gain, indicating that category momentum is concentrating among brands moving up the leaderboard as Lobo moves down; the trajectory implies Lobo’s share of consumer consideration is being redistributed to faster-rising competitors and will continue to erode unless the rank decline is arrested.
Notable Products
Bold - Blue Dream Infused Pre-Roll (1g) posted the standout move in September 2026 with a 79% month-over-month gain to rank 1, while Stardust Pure Diamond Powder (1g) slid 13% to rank 2. Blueberry Diesel Infused Flower (3.5g) fell 40% and sits at rank 3, and two of the top six are Pre-Roll SKUs, indicating momentum is skewing toward infused formats over traditional flower. This mix suggests Lobo is consolidating leadership around infused Pre-Rolls while trimming exposure where flower volatility is pulling ranks down.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
